ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification Number) | |
th Street |
||
(Address of principal executive offices) |
(Zip Code) |
Title of Each Class: |
Trading Symbol(s) |
Name of Each Exchange on Which Registered: | ||
one-half of one Redeemable Warrant |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ||||
Emerging growth company |
Auditor Firm Id: |
Auditor Name: |
Auditor Location: |
Item 12. |
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters |
• | each person known by us to be the beneficial owner of more than 5% of our outstanding ordinary shares; |
• | each of our executive officers and directors that beneficially owns our ordinary shares; and |
• | all our executive officers and directors as a group. |
Class B Ordinary Shares |
Approximate Percentage |
|||||||||||
Name and Address of Beneficial Owner(1) |
Number of Shares Beneficially Owned |
Approximate Percentage of Class |
of Outstanding Ordinary Shares |
|||||||||
Angel Pond Partners LLC (our sponsor)(2)(3) |
6,592,870 | 99.3 | % | 19.9 | % | |||||||
Theodore T. Wang(3)(4) |
6,592,870 | 99.3 | % | 19.9 | % | |||||||
Shihuang “Simon” Xie(3)(4) |
6,592,870 | 99.3 | % | 19.9 | % | |||||||
Mary Ann Cloyd |
22,500 | * | * | |||||||||
William A. Houlihan |
22,500 | * | * | |||||||||
Linden Capital L.P.(6) |
— | — | — | |||||||||
All directors and executive officers as a group (3 individuals)(3)(4) |
6,637,870 | 100 | % | 20.0 | % |
* | less than 1% |
(1) | Unless otherwise noted, the business address of each of the following is 45 East 85 th Street, 9E, New York, NY 10028. |
(2) | Interests shown consist solely of founder shares, classified as Class B Ordinary Shares. Such shares will automatically convert into Class A Ordinary Shares concurrently with or immediately following the consummation of our initial business combination on a one-for-one |
(3) | Angel Pond Partners LLC, our sponsor, is the record holder of the shares reported herein. Dr. Wang and an entity wholly owned and controlled by Mr. Xie are the co-managers of our sponsor and have joint voting and investment discretion with respect to the ordinary shares held of record by Angel Pond Partners LLC. Accordingly, the shares held by our sponsor may be deemed to be equally beneficially held by Dr. Wang and Mr. Xie. Dr. Wang and Mr. Xie disclaim beneficial ownership of the ordinary shares held of record by Angel Pond Partners LLC, except to the extent of any pecuniary interest therein. |
(4) | On March 15, 2021, our sponsor entered into forward purchase arrangements with certain institutional and professional accredited investors with whom Dr. Wang and Mr. Xie had pre-existing professional relationships pursuant to which our sponsor has agreed to transfer a total of 1,600,000 founder shares for upfront cash payments of $3.00 per share and 1,600,000 private placement warrants for upfront cash payments of $1.00 per warrant, for total aggregate consideration of $6,400,000, which our sponsor received prior to the date of the IPO. On January 28, 2022, our sponsor entered into another forward purchase arrangement pursuant to which our sponsor has agreed to transfer a total of 10,000 founder shares for upfront cash payments of $3.00 per share for total aggregate consideration of $30,000. These transactions were private resales to investors in reliance on the private placement doctrine and the so-called “4(a)(11 /2 )” exemption, and all of the resales were to sophisticated investors who are either qualified institutional buyers (as defined in Rule 144A under the Securities Act) or accredited investors (as defined in Rule 502 under the Securities Act) who had pre-existing relationships with the founders. These arrangements will be used by our sponsor to purchase a portion of the private placement warrants from us. The sponsor’s obligation to transfer the founder shares and private placement warrants pursuant to these arrangements is contingent upon consummation of an initial business combination and the expiration or termination of any lock-up arrangements in respect of those securities, including the lock-up arrangements described herein. Until the transfers are consummated, the sponsor will retain total voting and disposition control over the founder shares subject to the forward purchase agreements, subject to the future delivery obligations. In the event that an initial business combination is not consummated, the counterparties in these transactions will not receive any founder shares, private placement warrants or other consideration, and neither the sponsor nor the counterparties have any discretionary rights to unwind or otherwise redeem the securities. |
(5) | Linden Capital L.P. may have an interest in 750,000 founder shares upon the satisfaction of certain conditions, including the consummation of an initial business combination, as further described in footnote 4. |
Item 15. |
Exhibits, Financial Statements and Financial Statement Schedules |
Exhibit No. |
Description | |
31.1** | Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
31.2** | Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | |
32.1** | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
32.2** | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | |
104 | Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document contained in Exhibit 101** |
** |
Filed herewith |
August 2 9 , 2022 |
Angel Pond Holdings Corporation | |||||
By: | /s/ Theodore T. Wang | |||||
Name: | Theodore T. Wang | |||||
Title: | Chief Executive Officer (Principal Executive Officer) |
Name |
Position |
Date | ||
/s/ Theodore T. Wang |
Chief Executive Officer and Chairman | August 2 9 , 2022 | ||
Theodore T. Wang | (Principal Executive Officer) |
|||
/s/ Hanchen Jin |
Chief Financial Officer | August 2 9 , 2022 | ||
Hanchen Jin | (Principal Financial and Accounting Officer) |
|||
/s/ William A. Houlihan |
Director | August 2 9 , 2022 | ||
William A. Houlihan |
/s/ Samuel L. Milbank |
Director | August 29, 2022 | ||
Samuel L. Milbank | ||||
/s/ Mary Ann Cloyd |
Director | August 29, 2022 | ||
Mary Ann Cloyd |